733. Deputy Cathal Crowe asked the Minister for Health in respect of the treatment abroad scheme, the person or body within the HSE decides if a product is experimental; the criteria this decision maker uses to decide such and the definitions applied to experimental treatment; if the relevant decision makers have the expertise to review drugs for complex conditions; if the existing reimbursement list is referred to in making reimbursement decisions or whether EMA approval is deemed to be the over-riding proof of clinical safety; and if he will make a statement on the matter. [39088/22]

Summary

733. Deputy Cathal Crowe asked the Minister for Health in respect of the treatment abroad scheme, the person or body within the HSE decides if a product is experimental; the criteria this decision maker uses to decide such and the definitions applied to experimental treatment; if the relevant decision makers have the expertise to review drugs for complex conditions; if the existing reimbursement list is referred to in making reimbursement decisions or whether EMA approval is deemed to be the over-riding proof of clinical safety; and if he will make a statement on the matter. [39088/22]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Health Services

  xml · EN · 14 July 2022

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.